The Antimonopoly Committee of Ukraine (AMCU) has fined two manufacturers of dietary supplements for distributing misleading information about the properties of dietary supplements for a total of UAH 11.1 million.
According to the AMCU, VORVARTS PHARMA LLC was fined for distributing information on packaging and marketplaces about the properties of the dietary supplement ZAFAKOL IQ to improve intestinal function, which did not correspond to reality.
In turn, LLC “ERSEL PHARMA UKRAINE” distributed information about the properties of the dietary supplement “A-KETON” to eliminate the causes of acetone in children.
At the same time, AMCU notes that both companies provided publications on the properties of individual components of dietary supplements and/or articles on the use of dietary supplements in complex therapy with other drugs.
However, according to the position of the Ministry of Health, “such articles are not a sufficient basis for confirming the properties of dietary supplements, publications on the properties of individual components of dietary supplements do not confirm their presence in a dietary supplement as a whole.”
“The AMCU found that the information disseminated regarding the dietary supplements ZAFAKOL IQ and A-KETON may affect consumers’ intentions to purchase such products. At the same time, the information disseminated regarding these products may be perceived as properties that are inherent to a medicinal product,” AMCU noted.
AMCU did not specify the amount of the fine imposed on each of the companies.
The Antimonopoly Committee of Ukraine (AMCU) has fined Zdorovye Pharmaceutical Company (Kharkiv) for unlawful use of the packaging design of the drug Panthenol Plus, which is similar to the packaging design of the drug Bepanten Plus used by Bayer LLC.
According to the AMCU, the pharmaceutical company “Zdorovye” was fined UAH 719.348 thousand.
According to Bayer, the design of the package of the drug Panthenol Plus is similar to the design of the package of Bepanten Plus to the extent of mixing, and Bayer did not grant permission to use a similar design of the package of Bepanten Plus.
AMCU, Antimonopoly Committee of Ukraine (, Bayer LLC., Bepanten Plus, Panthenol Plus, Zdorovye Pharmaceutical Company
